A 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory.
TThe Syva MicroTrak Chlamydia enzyme immunoassay (EIA; Syva Company, San Jose, Calif.) with cytospin and direct fluorescent-antibody assay (DFA) confirmation was evaluated on 43,630 urogenital specimens over a 1-year period in the Provincial Laboratory in Regina, Saskatchewan, Canada. This was a two...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC263968/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7814548/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.32.9.2208-2211.1994 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|